McNeil Consumer Healthcare

By tcel
  • McNeil temporarily suspends production at Fort Washington plant

    McNeil Consumer Healthcare announced May 4 it had temporarily suspended production at its Fort Washington plant as a result of manufacturing deficiencies that led to a voluntary recall of several over-the-counter children's medications. Read more
  • Congress announces hearing on McNeil recall

    The House Committee on Oversight and Government Reform announced May 14 it would hold a hearing May 27 to explore what led McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, to recall more than 40 children's and infants' medications. Read more
  • Congress holds hearing on McNeil recalls

    Congress held its first hearing on McNeil Consumer Healthcare's massive recall of children's medication May 27, with testimony revealing the exact extent of the recall, leadership changes at the Fort Washington plant and the company's long-term compliance problems. Read more
  • McNeil's manufacturing problems prompt PediaCare recall

    Four PediaCare products are recalled in response to the FDA's announcement of serious manufacturing problems at McNeil Consumer Healthcare's Fort Washington plant. Read more
  • McNeil expands product recall

    The number of recalled products produced by McNeil Consumer Healthcare continued to grow, as the company announced an additional recall of popular Benadryl and Tylenol products June 15. Read more
  • McNeil announces plan will remain closed for remainder of year

    McNeil Consumer Healthcare has announced its Fort Washington plant will most likely remain closed for the remainder of this year. Read more
  • McNeil recalls lots of five different products

    The number of McNeil products being pulled off store shelves continued to increase, as the company initiated its seventh recall of the year July 8. Read more
  • McNeil lays off 300 at Fort Washington plant

    McNeil Consumer Healthcare announced July 15 it will be eliminating approximately 300 of its more than 400 positions at its Fort Washington plant. Read more
  • U.S. attorney general's office subpoenas McNeil record

    Johnson & Johnson announced the U.S. Attorney General's Office for the Eastern District of Pennsylvania has subpoenaed documents from McNeil Consumer Healthcare in regard to this year's multiple product recalls. Read more
  • Congress holds second hearing on McNeil recalls

    Congress held its second hearing on McNeil Consumer Healthcare’s string of recalls Sept. 30. Read more
  • McNeil recalls Tylenol produced in Fort Washington

    McNeil, a subsidiary of Johnson & Johnson, issued a recall Oct. 18 of one product lot of Tylenol 8 Hour caplets in 50-count bottles sold in the United States and Puerto Rico. Read more
  • McNeil recalls four more products

    McNeil Consumer Healthcare has added more items to its list of medications recalled in 2010, issuing voluntary recalls for more than 14 million bottles of four products. Read more
  • FDA cites McNeil's Fort Washington plant

    Even though it has been closed since the spring, McNeil Consumer Healthcare's Fort Washington plant continues to be the object of censure from the FDA.In a report released Dec. 15, the FDA noted investigators discovered quality control methods were not followed, product deficiencies were not fully investigated and records were not properly maintained. Read more
  • Oregon sues McNeil over 'phantom recall' of Motrin

    The Oregon Attorney General's Office has filed a lawsuit against McNeil Consumer Healthcare and Johnson & Johnson, alleging the companies violated the state's Unlawful Trade Practices Act by conducting a "phantom recall" of Motrin products. Read more
  • McNeil recalls Tylenol, other products

    McNeil issued a voluntary recall of more than 40 million packages of Benadryl, Sudafed, Tylenol and other products Jan. 15 due to insufficient equipment cleaning procedures. Read more
  • McNeil recalls adds up to $900 million loss for Johnson & Johnson

    While last year's numerous McNeil Consumer Healthcare recalls tarnished Johnson & Johnson's reputation, they also have had an impact on the company's finances to the tune of $900 million. Read more
  • Typo prompts McNeil recall of Sudafed

    A typographical error is behind the latest recall from Fort Washington-based pharmaceutical company McNeil Consumer Healthcare.The company issued a recall Feb. 24 of nine lots of Sudafed 24 Hour Extended-Release Tablets that were distributed in the United States. Read more
  • FDA files injunction against McNeil

    The FDA has filed a consent decree of permanent injunction against McNeil Consumer Healthcare and two of its top employees, preventing further production at McNeil’s Fort Washington plant and establishing strict oversight guidelines. Read more
  • McNeill issues another recall as Johnson & Johnson revamps consumer business

    As McNeil Consumer Healthcare issues another recall, its parent company, Johnson & Johnson, has released plans to reorganize its consumer business in order to pay closer attention to the troubled pharmaceutical subsidiary.
    Read more
  • Johnson & Johnson appoints new leadership at McNeil

    Along with restructuring its consumer business, Johnson & Johnson is hoping some new faces will help McNeil Consumer Healthcare rebound after a year of high-profile recalls. Read more